Literature DB >> 15005746

Prolonged allergen challenge in mice leads to persistent airway remodelling.

S J McMillan1, C M Lloyd.   

Abstract

BACKGROUND: Inflammatory infiltrates, airway hyper-responsiveness, goblet cell hyperplasia and subepithelial thickening are characteristic of chronic asthma. Current animal models of allergen-induced airway inflammation generally concentrate on the acute inflammation following allergen exposure and fail to mimic all of these features.
OBJECTIVE: The aim of this study was to use a murine model of prolonged allergen-induced airway inflammation in order to characterize the cells and molecules involved in the ensuing airway remodelling. Moreover, we investigated whether remodelling persists in the absence of continued allergen challenge.
METHODS: Acute pulmonary eosinophilia and airways hyper-reactivity were induced after six serial allergen challenges in sensitized mice (acute phase). Mice were subsequently challenged three times a week with ovalbumin (OVA) (chronic phase) up to day 55. To investigate the persistence of pathology, one group of mice were left for another 4 weeks without further allergen challenge (day 80).
RESULTS: The extended OVA challenge protocol caused significant airway remodelling, which was absent in the acute phase. Specifically, remodelling was characterized by deposition of collagen as well as airway smooth muscle and goblet cell hyperplasia. Importantly, these airway changes, together with tissue eosinophilia were sustained in the absence of further allergen challenge. Examination of cytokines revealed a dramatic up-regulation of IL-4 and tumour growth factor-beta1 during the chronic phase. Interestingly, while IL-4 levels were significantly increased during the chronic phase, levels of IL-13 fell. Levels of the Th1-associated cytokine IFN-gamma also increased during the chronic phase.
CONCLUSION: In conclusion, we have demonstrated that prolonged allergen challenge results in persistent airway wall remodelling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005746      PMCID: PMC3428844          DOI: 10.1111/j.1365-2222.2004.01895.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  49 in total

1.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

Authors:  P K Jeffery; A J Wardlaw; F C Nelson; J V Collins; A B Kay
Journal:  Am Rev Respir Dis       Date:  1989-12

2.  Subepithelial fibrosis in the bronchi of asthmatics.

Authors:  W R Roche; R Beasley; J H Williams; S T Holgate
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

Review 3.  The role of mucus in chronic obstructive pulmonary disease.

Authors:  A Wanner
Journal:  Chest       Date:  1990-02       Impact factor: 9.410

4.  Myofibroblasts and subepithelial fibrosis in bronchial asthma.

Authors:  C E Brewster; P H Howarth; R Djukanovic; J Wilson; S T Holgate; W R Roche
Journal:  Am J Respir Cell Mol Biol       Date:  1990-11       Impact factor: 6.914

5.  Lung inflammation and epithelial changes in a murine model of atopic asthma.

Authors:  D I Blyth; M S Pedrick; T J Savage; E M Hessel; D Fattah
Journal:  Am J Respir Cell Mol Biol       Date:  1996-05       Impact factor: 6.914

6.  Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma.

Authors:  M Cembrzynska-Nowak; E Szklarz; A D Inglot; J A Teodorczyk-Injeyan
Journal:  Am Rev Respir Dis       Date:  1993-02

7.  CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.

Authors:  A Hartnell; D S Robinson; A B Kay; A J Wardlaw
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

8.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

Authors:  C J Corrigan; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-04

9.  Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets.

Authors:  G D Sempowski; S Derdak; R P Phipps
Journal:  J Cell Physiol       Date:  1996-05       Impact factor: 6.384

10.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Authors:  P S Foster; S P Hogan; A J Ramsay; K I Matthaei; I G Young
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  80 in total

1.  Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.

Authors:  Erik J Stemmy; Molly A Balsley; Rosalyn A Jurjus; Jesse M Damsker; Michael I Bukrinsky; Stephanie L Constant
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

Review 2.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

3.  Establishment and characterization of an experimental mouse model of allergic rhinitis.

Authors:  Ming-Tse Ko; Shun-Chen Huang; Hong-Yo Kang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-16       Impact factor: 2.503

4.  Prolonged ovalbumin challenge facilitates Th17 polarization in sensitized mice.

Authors:  Qing Wang; Hequan Li; Zhiyuan Zhang; Yinan Yao; Jianying Zhou
Journal:  Inflamm Res       Date:  2010-02-14       Impact factor: 4.575

Review 5.  Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma.

Authors:  Pieter Bogaert; Kurt G Tournoy; Thomas Naessens; Johan Grooten
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 6.  Allergen-induced airway remodelling.

Authors:  C M Lloyd; D S Robinson
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

7.  Arsenic trioxide alleviates airway hyperresponsiveness and promotes apoptosis of CD4+ T lymphocytes: evidence for involvement of the ER stress-CHOP pathway.

Authors:  K Li; L Zhang; X Xiang; S Gong; L Ma; L Xu; G Wang; Y Liu; X Ji; S Liu; P Chen; H Zeng; J Li
Journal:  Ir J Med Sci       Date:  2013-03-14       Impact factor: 1.568

8.  A new approach for analyzing cellular infiltration during allergic airway inflammation.

Authors:  Peter R Hoffmann; Alexandra Gurary; Fukun W Hoffmann; Claude Jourdan-Le Saux; Kelsa Teeters; Ann C Hashimoto; Elizabeth K Tam; Marla J Berry
Journal:  J Immunol Methods       Date:  2007-08-27       Impact factor: 2.303

9.  Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model.

Authors:  S Yamagata; K Tomita; R Sato; A Niwa; H Higashino; Y Tohda
Journal:  Clin Exp Immunol       Date:  2008-09-23       Impact factor: 4.330

10.  CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.

Authors:  Jennifer Kearley; Douglas S Robinson; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2008-07-30       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.